These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Efficacy and safety of terbinafine hydrochloride spray and 3% boric acid alcohol ear drops in otomycosis. Xu S; Li J; Ding L; Gao K; Xie F; Han J; Zhou X Acta Otolaryngol; 2020 Apr; 140(4):302-306. PubMed ID: 32022618 [No Abstract] [Full Text] [Related]
29. Recent advances in therapies for onychomycosis and its management. Gupta AK; Stec N F1000Res; 2019; 8():. PubMed ID: 31297182 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin - A prospective, randomized comparative study. Bhatia A; Kanish B; Badyal DK; Kate P; Choudhary S Indian J Pharmacol; 2019; 51(2):116-119. PubMed ID: 31142947 [TBL] [Abstract][Full Text] [Related]
31. A pilot, layerwise, ex vivo evaluation of the antifungal efficacy of amorolfine 5% nail lacquer vs other topical antifungal nail formulations in healthy toenails. Ghannoum M; Long L; Kunze G; Sarkany M; Osman-Ponchet H Mycoses; 2019 Jun; 62(6):494-501. PubMed ID: 30667544 [TBL] [Abstract][Full Text] [Related]
32. Challenges and Opportunities in the Management of Onychomycosis. Christenson JK; Peterson GM; Naunton M; Bushell M; Kosari S; Baby KE; Thomas J J Fungi (Basel); 2018 Jul; 4(3):. PubMed ID: 30042327 [TBL] [Abstract][Full Text] [Related]
33. Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics. Yousefian F; Smythe C; Han H; Elewski BE; Nestor M J Clin Aesthet Dermatol; 2024 Mar; 17(3):24-33. PubMed ID: 38495549 [TBL] [Abstract][Full Text] [Related]
34. Nail Society of India (NSI) Recommendations for Pharmacologic Therapy of Onychomycosis. Mahajan K; Grover C; Relhan V; Tahiliani S; Singal A; Shenoy MM; Jakhar D Indian Dermatol Online J; 2023; 14(3):330-341. PubMed ID: 37266092 [TBL] [Abstract][Full Text] [Related]
35. Updated Perspectives on the Diagnosis and Management of Onychomycosis. Falotico JM; Lipner SR Clin Cosmet Investig Dermatol; 2022; 15():1933-1957. PubMed ID: 36133401 [TBL] [Abstract][Full Text] [Related]
36. A Paradigm Shift in the Treatment and Management of Onychomycosis. Gupta AK; Venkataraman M; Renaud HJ; Summerbell R; Shear NH; Piguet V Skin Appendage Disord; 2021 Aug; 7(5):351-358. PubMed ID: 34604322 [TBL] [Abstract][Full Text] [Related]
37. A comparative study between two antifungal agents, Luliconazole and Efinaconazole, of their preventive effects in a Trichophyton-infected guinea pig onychomycosis model. Nakamura A; Hirakawa S; Nagai H; Inagaki K Med Mycol; 2021 Mar; 59(3):289-295. PubMed ID: 33539539 [TBL] [Abstract][Full Text] [Related]
38. Onychomycosis: An Updated Review. Leung AKC; Lam JM; Leong KF; Hon KL; Barankin B; Leung AAM; Wong AHC Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):32-45. PubMed ID: 31738146 [TBL] [Abstract][Full Text] [Related]
39. Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure. Shemer A; Gupta AK; Kamshov A; Babaev M; Farhi R; Daniel CR; Foley KA Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28856784 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial. Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]